THE MORISKY MEDICATION ADHERENCE SCALE 8 ITEM

End-User License Agreement (EULA) for Authorization to Use the MMAS in Research and Publication

1. Introduction

This End-User License Agreement (EULA) is a legal agreement between the user ("Licensee") and MMAR, LLC dba ADHERENCE ("Licensor") of the Morisky Medication Adherence Scale (MMAS). By using the MMAS for research and publication, the Licensee agrees to be bound by the terms and conditions of this EULA.

2. Grant of License

The Licensor grants the Licensee a non-exclusive, non-transferable, limited license to use the MMAS for the purposes of research and publication as specified herein. This license is granted on the condition that the Licensee adheres to all terms and conditions set forth in this EULA.

3. Use Restrictions

The Licensee agrees to use the MMAS solely for academic, clinical, or research purposes. The Licensee shall not:

- Distribute, sublicense, lease, sell, or otherwise transfer the MMAS to any third party.

- Reverse engineer, decompile, or disassemble the MMAS.

- Publish, disclose, or share the MMAS scoring algorithm, which remains a protected trade secret of the Licensor.

4. Confidentiality

The Licensee acknowledges that the MMAS scoring algorithm is confidential and proprietary information. The Licensee agrees to:

- Maintain the confidentiality of the scoring algorithm.

- Take all reasonable measures to protect the confidentiality of the scoring algorithm.

- Not disclose the scoring algorithm to any third party without the prior written consent of the Licensor.

5. Data Reporting and Publication

The Licensee may use the MMAS in research and publications under the following conditions:

- Proper attribution must be given to the Licensor in any research reports, articles, or publications that include data derived from the MMAS.

             ©MMAS 2006 www.adherence.cc 

- The Licensee must provide the Licensor with a copy of any published research that includes data derived from the MMAS.

- The Licensee may not disclose the detailed scoring algorithm in any publication or presentation.

- The scoring must be posted as follows:

 The MMAS-8 scale consists of 8  items. Each of the first 7 items has 2  possible responses (yes/no), while the  8th item is answered with a 5-point Likert  scale. The possible total medication  adherence score ranges between 0 and  8, and the higher the score, the better  the adherence level. A total score < 6 is  considered low adherence, while a total  score of ≥ 6 but < 8 indicates moderate adherence, and a score of 8 indicates  high adherence. 

6. Ownership

The MMAS and all associated intellectual property rights remain the sole property of the Licensor. This EULA does not grant the Licensee any ownership rights in the MMAS or its scoring algorithm.

7. Termination

This license is effective until terminated. The Licensor may terminate this license at any time if the Licensee breaches any of the terms and conditions of this EULA. Upon termination, the Licensee must cease all use of the MMAS and destroy all copies of the MMAS in their possession.

8. Limitation of Liability

The MMAS is provided "as is" without any warranties, express or implied. The Licensor shall not be liable for any damages arising out of or in connection with the use or performance of the MMAS.

9. Governing Law

This EULA shall be governed by and construed in accordance with the laws of the state of California, without regard to its conflict of laws principles.

10. Entire Agreement

This EULA constitutes the entire agreement between the Licensee and the Licensor with respect to the use of the MMAS and supersedes all prior or contemporaneous understandings regarding such subject matter.

11. Amendments

The Licensor reserves the right to amend the terms of this EULA at any time. Any amendments will be effective upon notice to the Licensee.

By using the MMAS, you acknowledge that you have read, understood, and agree to be bound by the terms and conditions of this EULA.